Global Bone Viscosupplementation 麻豆原创 Research Report 2024

Publication ID:

PB505251912

Publication Date:

May 10, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
The global Bone Viscosupplementation market was valued at US$ 1822 million in 2023 and is anticipated to reach US$ 2329.4 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.
This report aims to provide a comprehensive presentation of the global market for Bone Viscosupplementation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone Viscosupplementation.
Report Scope
The Bone Viscosupplementation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bone Viscosupplementation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bone Viscosupplementation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Segment by Type
Single Injection
Three Injection
Five Injection
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bone Viscosupplementation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bone Viscosupplementation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Bone Viscosupplementation 麻豆原创 Overview
1.1 Product Overview and Scope of Bone Viscosupplementation
1.2 Bone Viscosupplementation Segment by Type
1.2.1 Global Bone Viscosupplementation 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Single Injection
1.2.3 Three Injection
1.2.4 Five Injection
1.3 Bone Viscosupplementation Segment by Application
1.3.1 Global Bone Viscosupplementation 麻豆原创 Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Bone Viscosupplementation 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Bone Viscosupplementation Revenue 2019-2030
1.4.2 Global Bone Viscosupplementation Sales 2019-2030
1.4.3 Global Bone Viscosupplementation 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bone Viscosupplementation 麻豆原创 Competition by Manufacturers
2.1 Global Bone Viscosupplementation Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Bone Viscosupplementation Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Bone Viscosupplementation Average Price by Manufacturers (2019-2024)
2.4 Global Bone Viscosupplementation Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bone Viscosupplementation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bone Viscosupplementation, Product Type & Application
2.7 Bone Viscosupplementation 麻豆原创 Competitive Situation and Trends
2.7.1 Bone Viscosupplementation 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bone Viscosupplementation Players 麻豆原创 Share by Revenue
2.7.3 Global Bone Viscosupplementation 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bone Viscosupplementation Retrospective 麻豆原创 Scenario by Region
3.1 Global Bone Viscosupplementation 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bone Viscosupplementation Global Bone Viscosupplementation Sales by Region: 2019-2030
3.2.1 Global Bone Viscosupplementation Sales by Region: 2019-2024
3.2.2 Global Bone Viscosupplementation Sales by Region: 2025-2030
3.3 Global Bone Viscosupplementation Global Bone Viscosupplementation Revenue by Region: 2019-2030
3.3.1 Global Bone Viscosupplementation Revenue by Region: 2019-2024
3.3.2 Global Bone Viscosupplementation Revenue by Region: 2025-2030
3.4 North America Bone Viscosupplementation 麻豆原创 Facts & Figures by Country
3.4.1 North America Bone Viscosupplementation 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bone Viscosupplementation Sales by Country (2019-2030)
3.4.3 North America Bone Viscosupplementation Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bone Viscosupplementation 麻豆原创 Facts & Figures by Country
3.5.1 Europe Bone Viscosupplementation 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bone Viscosupplementation Sales by Country (2019-2030)
3.5.3 Europe Bone Viscosupplementation Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bone Viscosupplementation 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Bone Viscosupplementation 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bone Viscosupplementation Sales by Country (2019-2030)
3.6.3 Asia Pacific Bone Viscosupplementation Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bone Viscosupplementation 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Bone Viscosupplementation 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bone Viscosupplementation Sales by Country (2019-2030)
3.7.3 Latin America Bone Viscosupplementation Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bone Viscosupplementation 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Bone Viscosupplementation 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bone Viscosupplementation Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bone Viscosupplementation Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bone Viscosupplementation Sales by Type (2019-2030)
4.1.1 Global Bone Viscosupplementation Sales by Type (2019-2024)
4.1.2 Global Bone Viscosupplementation Sales by Type (2025-2030)
4.1.3 Global Bone Viscosupplementation Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Bone Viscosupplementation Revenue by Type (2019-2030)
4.2.1 Global Bone Viscosupplementation Revenue by Type (2019-2024)
4.2.2 Global Bone Viscosupplementation Revenue by Type (2025-2030)
4.2.3 Global Bone Viscosupplementation Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Bone Viscosupplementation Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bone Viscosupplementation Sales by Application (2019-2030)
5.1.1 Global Bone Viscosupplementation Sales by Application (2019-2024)
5.1.2 Global Bone Viscosupplementation Sales by Application (2025-2030)
5.1.3 Global Bone Viscosupplementation Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Bone Viscosupplementation Revenue by Application (2019-2030)
5.2.1 Global Bone Viscosupplementation Revenue by Application (2019-2024)
5.2.2 Global Bone Viscosupplementation Revenue by Application (2025-2030)
5.2.3 Global Bone Viscosupplementation Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Bone Viscosupplementation Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Bone Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Bone Viscosupplementation Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Anika Therapeutics
6.2.1 Anika Therapeutics Corporation Information
6.2.2 Anika Therapeutics Description and Business Overview
6.2.3 Anika Therapeutics Bone Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Anika Therapeutics Bone Viscosupplementation Product Portfolio
6.2.5 Anika Therapeutics Recent Developments/Updates
6.3 Seikagaku
6.3.1 Seikagaku Corporation Information
6.3.2 Seikagaku Description and Business Overview
6.3.3 Seikagaku Bone Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Seikagaku Bone Viscosupplementation Product Portfolio
6.3.5 Seikagaku Recent Developments/Updates
6.4 Zimmer Biomet
6.4.1 Zimmer Biomet Corporation Information
6.4.2 Zimmer Biomet Description and Business Overview
6.4.3 Zimmer Biomet Bone Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zimmer Biomet Bone Viscosupplementation Product Portfolio
6.4.5 Zimmer Biomet Recent Developments/Updates
6.5 Bioventus
6.5.1 Bioventus Corporation Information
6.5.2 Bioventus Description and Business Overview
6.5.3 Bioventus Bone Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bioventus Bone Viscosupplementation Product Portfolio
6.5.5 Bioventus Recent Developments/Updates
6.6 Ferring
6.6.1 Ferring Corporation Information
6.6.2 Ferring Description and Business Overview
6.6.3 Ferring Bone Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ferring Bone Viscosupplementation Product Portfolio
6.6.5 Ferring Recent Developments/Updates
6.7 LG Chem
6.6.1 LG Chem Corporation Information
6.6.2 LG Chem Description and Business Overview
6.6.3 LG Chem Bone Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LG Chem Bone Viscosupplementation Product Portfolio
6.7.5 LG Chem Recent Developments/Updates
6.8 Freda
6.8.1 Freda Corporation Information
6.8.2 Freda Description and Business Overview
6.8.3 Freda Bone Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Freda Bone Viscosupplementation Product Portfolio
6.8.5 Freda Recent Developments/Updates
6.9 Haohai Biological
6.9.1 Haohai Biological Corporation Information
6.9.2 Haohai Biological Description and Business Overview
6.9.3 Haohai Biological Bone Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Haohai Biological Bone Viscosupplementation Product Portfolio
6.9.5 Haohai Biological Recent Developments/Updates
6.10 Shanghai Jingfeng
6.10.1 Shanghai Jingfeng Corporation Information
6.10.2 Shanghai Jingfeng Description and Business Overview
6.10.3 Shanghai Jingfeng Bone Viscosupplementation Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shanghai Jingfeng Bone Viscosupplementation Product Portfolio
6.10.5 Shanghai Jingfeng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bone Viscosupplementation Industry Chain Analysis
7.2 Bone Viscosupplementation Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bone Viscosupplementation Production Mode & Process
7.4 Bone Viscosupplementation Sales and 麻豆原创ing
7.4.1 Bone Viscosupplementation Sales Channels
7.4.2 Bone Viscosupplementation Distributors
7.5 Bone Viscosupplementation Customers
8 Bone Viscosupplementation 麻豆原创 Dynamics
8.1 Bone Viscosupplementation Industry Trends
8.2 Bone Viscosupplementation 麻豆原创 Drivers
8.3 Bone Viscosupplementation 麻豆原创 Challenges
8.4 Bone Viscosupplementation 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.